Saudi Arabia Dengue Testing Market Size, Share & Trends Analysis Report By Test Type (ELISA Based Tests, Molecular Diagnostic Tests, Rapid Diagnostic Tests (RDTs)), By Product (Consumables, Instruments), By End Use (Hospitals), And Segment Forecasts, 2026 - 2033
Saudi Arabia Dengue Testing Market Size & Trends The Saudi Arabia dengue testing market was valued at USD 624.35 thousand in 2025 and is projected to grow from USD 654.00 thousand in 2026 to re... もっと見る
英語原文をAIを使って翻訳しています。
SummarySaudi Arabia Dengue Testing Market Size & TrendsThe Saudi Arabia dengue testing market was valued at USD 624.35 thousand in 2025 and is projected to grow from USD 654.00 thousand in 2026 to reach USD 889.83 thousand by 2033, growing at a CAGR of 4.50% from 2026 to 2033. The market is driven by the increasing prevalence of dengue infections, particularly in western and southern regions such as Jeddah, Makkah, and Jazan. Rising mosquito-borne disease surveillance activities and growing awareness of early diagnosis are increasing demand for accurate dengue testing methods, including RT-PCR, ELISA, NS1 antigen testing, and rapid diagnostic tests (RDTs). Saudi Arabia Dengue Testing Market Report Segmentation This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Saudi Arabia dengue testing market report based on test type, product, and end use: • Test Type (Revenue, USD Thousands, 2021 - 2033) o ELISA-Based Tests o Molecular Diagnostic Kits o Rapid Diagnostic Tests (RDTs) o Lateral Flow Assays (Antigen-Based) • Product Outlook (Revenue, USD Thousands, 2021 - 2033) o Consumables o Instruments o Others • End Use Outlook (Revenue, USD Thousands, 2021 - 2033) o Hospitals o Diagnostic Laboratories o Government & Public Health Laboratories o Research Institutes Table of ContentsTable of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation and Scope 1.1.1. Segment Definitions 1.1.1.1. Test Type Segment 1.1.1.2. Product Segment 1.1.1.3. End Use Segment 1.2. Estimates and Forecast Timeline 1.2.1. Objectives 1.2.2. Objective - 1 1.2.3. Objective - 2 1.2.4. Objective - 3 1.3. Research Methodology 1.4. Information Procurement 1.4.1. Purchased Database 1.4.2. GVR’s Internal Database 1.4.3. Secondary Sources 1.4.4. Primary Research 1.5. Information or Data Analysis 1.5.1. Data Analysis Models 1.6. Market Formulation & Validation 1.7. Model Details 1.7.1. Commodity Flow Analysis 1.8. List of Secondary Sources 1.9. List of Abbreviations Chapter 2. Executive Summary 2.1. Market Snapshot 2.2. Test Type & Product Snapshot 2.3. End Use Snapshot 2.4. Competitive Landscape Snapshot Chapter 3. Market Variables, Trends, & Scope 3.1. Market Lineage Outlook 3.1.1. Parent Market Outlook 3.1.2. Related/Ancillary Market Outlook 3.2. Market Dynamics 3.2.1. Market Driver Analysis 3.2.1.1. Rising incidence of dengue cases and mosquito-borne diseases 3.2.1.2. Government initiatives and expansion of healthcare infrastructure 3.2.1.3. Growing adoption of advanced diagnostic technologies 3.2.2. Market Restraint Analysis 3.2.2.1. High costs of advanced diagnostic technologies 3.2.2.2. Limited awareness and underdiagnoses in certain countries 3.3. Industry Analysis Tools 3.3.1. Porter’s Five Forces Analysis 3.3.2. PESTEL Analysis Chapter 4. Test Type Business Analysis 4.1. Saudi Arabia Dengue Testing Market: Test Type Movement Analysis 4.2. ELISA-Based Tests 4.2.1. ELISA-based Tests Market, 2021 - 2033 (USD Thousands) 4.3. Molecular Diagnostic Kits 4.3.1. Molecular Diagnostic Kits Market, 2021 - 2033 (USD Thousands) 4.4. Rapid Diagnostic Tests (RDTs) 4.4.1. Rapid Diagnostic Tests (RDTs) Market, 2021 - 2033 (USD Thousands) 4.5. Lateral Flow Assays (Antigen-Based) 4.5.1. Lateral Flow Assays (Antigen-based) Market, 2021 - 2033 (USD Thousands) Chapter 5. Product Business Analysis 5.1. Saudi Arabia Dengue Testing Market: Product Movement Analysis 5.2. Consumables 5.2.1. Consumables Market, 2021 - 2033 (USD Thousands) 5.3. Instruments 5.3.1. Instruments Market, 2021 - 2033 (USD Thousands) 5.4. Others 5.4.1. Others Market, 2021 - 2033 (USD Thousands) Chapter 6. End Use Business Analysis 6.1. Hospitals 6.1.1. Hospitals Market, 2021 - 2033 (USD Thousands) 6.2. Diagnostic Laboratories 6.2.1. Diagnostic Laboratories Market, 2021 - 2033 (USD Thousands) 6.3. Government & Public Health Laboratories 6.3.1. Government & Public Health Laboratories Market, 2021 - 2033 (USD Thousands) 6.4. Research Institutes 6.4.1. Research Institutes Market, 2021 - 2033 (USD Thousands) Chapter 7. Competitive Landscape 7.1. Company Categorization 7.2. Strategy Mapping 7.3. Company Market Share Analysis, 2025 7.4. Company Profiles/Listing 7.4.1. Abbott 7.4.1.1. Overview 7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit) 7.4.1.3. Technology Benchmarking 7.4.1.4. Strategic Initiatives 7.4.2. F. Hoffmann-La Roche Ltd 7.4.2.1. Overview 7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit) 7.4.2.3. Technology Benchmarking 7.4.2.4. Strategic Initiatives 7.4.3. Thermo Fisher Scientific, Inc. 7.4.3.1. Overview 7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit) 7.4.3.3. Technology Benchmarking 7.4.3.4. Strategic Initiatives 7.4.4. Bio-Rad Laboratories, Inc. 7.4.4.1. Overview 7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit) 7.4.4.3. Technology Benchmarking 7.4.4.4. Strategic Initiatives 7.4.5. SD Biosensor 7.4.5.1. Overview 7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit) 7.4.5.3. Technology Benchmarking 7.4.5.4. Strategic Initiatives 7.4.6. QuidelOrtho Corporation 7.4.6.1. Overview 7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit) 7.4.6.3. Technology Benchmarking 7.4.6.4. Strategic Initiatives 7.4.7. InBios International, Inc. 7.4.7.1. Overview 7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit) 7.4.7.3. Technology Benchmarking 7.4.7.4. Strategic Initiatives 7.4.8. CTK Biotech, Inc. 7.4.8.1. Overview 7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit) 7.4.8.3. Technology Benchmarking 7.4.8.4. Strategic Initiatives 7.4.9. GENBODY INC. 7.4.9.1. Overview 7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit) 7.4.9.3. Technology Benchmarking 7.4.9.4. Strategic Initiatives List of Tables/GraphsList of TablesTable 1 List of abbreviation Table 2 Saudi Arabia dengue testing market, by test type, 2021 - 2033 (USD Thousands) Table 3 Saudi Arabia dengue testing market, by product, 2021 - 2033 (USD Thousands) Table 4 Saudi Arabia dengue testing market, by end use, 2021 - 2033 (USD Thousands)List of Figures Fig. 1 Saudi Arabia dengue testing market segmentation Fig. 2 Market research process Fig. 3 Data triangulation techniques Fig. 4 Primary research pattern Fig. 5 Market research approaches Fig. 6 Value chain based sizing & forecasting Fig. 7 QFD modelling for market share assessment Fig. 8 Market formulation & validation Fig. 9 Market snapshot Fig. 10 Test type and product segment snapshot Fig. 11 End use segment snapshot Fig. 12 Competitive landscape snapshot Fig. 13 In Vitro Diagnostics (IVD) market value, 2025 (USD Billion) Fig. 14 Market trends & outlook Fig. 15 Porter’s five force analysis Fig. 16 PESTEL analysis Fig. 17 Saudi Arabia dengue testing market: Test type outlook and key takeaways Fig. 18 Saudi Arabia dengue testing market: Test type movement analysis Fig. 19 ELISA-based tests market estimates and forecast, 2021 - 2033 (USD Thousands) Fig. 20 Molecular diagnostic kits market estimates and forecast, 2021 - 2033 (USD Thousands) Fig. 21 Rapid diagnostic tests (RDTs) market estimates and forecast, 2021 - 2033 (USD Thousands) Fig. 22 Lateral flow assays (antigen-based) market estimates and forecast, 2021 - 2033 (USD Thousands) Fig. 23 Saudi Arabia dengue testing market: Product outlook and key takeaways Fig. 24 Saudi Arabia dengue testing market: Product movement analysis Fig. 25 Consumables market estimates and forecast, 2021 - 2033 (USD Thousands) Fig. 26 Instruments market estimates and forecast, 2021 - 2033 (USD Thousands) Fig. 27 Others market estimates and forecast, 2021 - 2033 (USD Thousands) Fig. 28 Saudi Arabia dengue testing market: End use outlook and key takeaways Fig. 29 Saudi Arabia dengue testing market: End use movement analysis Fig. 30 Hospitals market estimates and forecast, 2021 - 2033 (USD Thousands) Fig. 31 Diagnostic laboratories market estimates and forecast, 2021 - 2033 (USD Thousands) Fig. 32 Government & public health laboratories market estimates and forecast, 2021 - 2033 (USD Thousands) Fig. 33 Research institutes market estimates and forecast, 2021 - 2033 (USD Thousands) Fig. 34 Key company categorization Fig. 35 Company market share analysis, 2025 Fig. 36 Strategic framework
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
Grand View Research社の 臨床検査分野 での最新刊レポート
本レポートと同じKEY WORD(molecular diagnostic)の最新刊レポートよくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|